Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,604,359
-
Total 13F shares
-
55,340,731
-
Share change
-
-516,505
-
Total reported value
-
$5,467,195,169
-
Put/Call ratio
-
53%
-
Price per share
-
$98.92
-
Number of holders
-
298
-
Value change
-
+$30,463,584
-
Number of buys
-
144
-
Number of sells
-
154
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q2 2020
As of 30 Jun 2020 TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) had 298 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 55,340,731 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Invesco Ltd., GILDER GAGNON HOWE & CO LLC, FEDERATED HERMES, INC., FRED ALGER MANAGEMENT, LLC, BROWN CAPITAL MANAGEMENT LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 298 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.